Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
- PMID: 36483910
- PMCID: PMC9727256
- DOI: 10.17179/excli2022-5355
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
Abstract
The severe acute respiratory syndrome (SARS-CoV, now SARS-CoV-1), middle east respiratory syndrome (MERS-CoV), Neo-CoV, and 2019 novel coronavirus (SARS-CoV-2/COVID-19) are the most notable coronaviruses, infecting the number of people worldwide by targeting the respiratory system. All these viruses are of zoonotic origin, predominantly from bats which are one of the natural reservoir hosts for coronaviruses. Thus, the major goal of our review article is to compare and contrast the characteristics and attributes of these coronaviruses. The SARS-CoV-1, MERS-CoV, and COVID-19 have many viral similarities due to their classification, they are not genetically related. COVID-19 shares approximately 79 % of its genome with SARS-CoV-1 and about 50 % with MERS-CoV. The shared receptor protein, ACE2 exhibit the most striking genetic similarities between SARS-CoV-1 and SARS-CoV-2. SARS-CoV primarily replicates in the epithelial cells of the respiratory system, but it may also affect macrophages, monocytes, activated T cells, and dendritic cells. MERS-CoV not only infects and replicates inside the epithelial and immune cells, but it may lyse them too, which is one of the common reasons for MERS's higher mortality rate. The details of infections caused by SARS-CoV-2 and lytic replication mechanisms in host cells are currently mysterious. In this review article, we will discuss the comparative highlights of SARS-CoV-1, MERS-CoV, SARS-CoV-2, and Neo-CoV, concerning their structural features, morphological characteristics, sources of virus origin and their evolutionary transitions, infection mechanism, computational study approaches, pathogenesis and their severity towards several diseases, possible therapeutic approaches, and preventive measures.
Keywords: COVID; MERS-CoV; Neo-CoV; SARS-CoV-1; SARS-CoV-2; coronavirus; respiratory syndrome.
Copyright © 2022 Goyal et al.
Figures





Similar articles
-
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.J Virol. 2016 Sep 12;90(19):8924-33. doi: 10.1128/JVI.01429-16. Print 2016 Oct 1. J Virol. 2016. PMID: 27466418 Free PMC article.
-
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6. Infect Dis Poverty. 2020. PMID: 32690096 Free PMC article. Review.
-
From SARS coronavirus to novel animal and human coronaviruses.J Thorac Dis. 2013 Aug;5 Suppl 2(Suppl 2):S103-8. doi: 10.3978/j.issn.2072-1439.2013.06.02. J Thorac Dis. 2013. PMID: 23977429 Free PMC article.
-
[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].Vopr Virusol. 2020;65(2):62-70. doi: 10.36233/0507-4088-2020-65-2-62-70. Vopr Virusol. 2020. PMID: 32515561 Review. Russian.
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
Cited by
-
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2.Arch Pharm (Weinheim). 2025 Jan;358(1):e2400545. doi: 10.1002/ardp.202400545. Epub 2024 Nov 9. Arch Pharm (Weinheim). 2025. PMID: 39520338 Free PMC article.
-
Investigation of influential environmental and climatic determinants on COVID-19 spread in India to formulate a sustainable pandemic response.One Health. 2025 Apr 16;20:101042. doi: 10.1016/j.onehlt.2025.101042. eCollection 2025 Jun. One Health. 2025. PMID: 40331077 Free PMC article.
-
Liver Damage and COVID-19: At Least a "Two-Hit" Story in Systematic Review.Curr Issues Mol Biol. 2023 Apr 4;45(4):3035-3047. doi: 10.3390/cimb45040199. Curr Issues Mol Biol. 2023. PMID: 37185723 Free PMC article. Review.
-
Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury.Front Immunol. 2025 May 14;16:1561946. doi: 10.3389/fimmu.2025.1561946. eCollection 2025. Front Immunol. 2025. PMID: 40438117 Free PMC article. Review.
-
Plasma EV-miRNAs as Potential Biomarkers of COVID-19 Vaccine Immune Response in Cancer Patients.Vaccines (Basel). 2024 Jul 28;12(8):848. doi: 10.3390/vaccines12080848. Vaccines (Basel). 2024. PMID: 39203974 Free PMC article.
References
-
- Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29. doi: 10.1186/s40249-020-00646-x. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous